Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison

Aug.25.2025
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.

Key Points:

·Etomidate Classification: From September 1, etomidate will be classified as a Class C drug under Singapore's Misuse of Drugs Act.

·Health Risks: Etomidate-laced e-cigarettes, known as "zombie pods," pose serious health risks, including nausea, muscle spasms, and potential death.

·Enforcement Actions: Singapore has intensified enforcement efforts, seizing over 850 e-cigarettes and related products in recent operations.

·Legal Penalties: Users face mandatory rehabilitation and potential prosecution. Traffickers and distributors face up to 20 years in prison and caning.

·Tourism Impact: Local tour guides and travel agencies are informing tourists about the new regulations to ensure compliance and avoid penalties.

 


 

According to reports from various media outlets, including Lianhe Zaobao and 8world, Singapore will classify the anesthetic etomidate as a Class C drug from Sept. 1. Traffickers and users may face prosecution and a minimum one-year jail term.

 

Etomidate, mixed into e-cigarettes, is widely circulated and highly addictive. Prime Minister Wong recently announced that the government will treat e-cigarettes as a drug issue, stepping up enforcement and education. E-cigarettes containing etomidate, also known as "zombie pods," pose serious health risks, including nausea, muscle spasms, and even death.

 

Once classified as a Class C drug, users will undergo mandatory supervision and rehabilitation. Repeat offenders may face prosecution and a minimum one-year jail term. Sellers, distributors, and importers may face up to 20 years in prison and caning. Currently, etomidate is regulated under the Poisons Act, with no mandatory rehabilitation or criminal liability for users.

 

Under Section 59 of the Misuse of Drugs Act, the home minister can amend the first, third, fourth, and fifth schedules via gazette, without parliamentary debate. Other Class C drugs include benzphetamine, mephentermine, and nimetazepam.

 

To prevent e-cigarettes from entering the country, Singapore's checkpoints have intensified enforcement. In five days, 184 cases involving e-cigarettes were detected, with over 850 e-cigarettes and accessories seized.

 

Local tour guide Chen Lizhen said that before tourists enter Singapore, she will communicate with the group leaders to remind them of Singapore's entry regulations, especially regarding e-cigarettes and smuggled cigarettes. Upon arrival in Singapore, she will also remind tourists again to ensure they understand the local laws.

 

Dallas Travel Agency pointed out that there is already a set procedure to notify foreign tourists in advance that they are not allowed to bring e-cigarettes into the country. The company then also clearly informed tourists that bringing e-cigarettes would face serious penalties.

 

Super Travel Group Vice President and Marketing Director Huang Haixiao said: "We don't think this will affect inbound tourism because everyone knows that Singapore is a disciplined country, and our previous bans on drugs and chewing gum have not affected Singapore's inbound tourism."

 

O & E Holidays Joint Reviewer Huang Yaoxiong believes that this regulation can help Singapore build a cleaner and safer tourist destination and attract more families to travel to Singapore.

 

Experts pointed out that some tourists may think that smoking e-cigarettes is not serious, but once they are informed that they will face serious penalties, their attitudes will also change.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysia’s High Court ruled that the government’s earlier decision to remove liquid nicotine from the country’s Poisons List was “irrational,” reigniting debate over vape regulation, illicit trade, and youth protection.
Regulations
May.18
Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands has outlined what the newly approved UK Tobacco and Vapes Act 2026 means for retailers. The legislation received Royal Assent on April 29, 2026, and gives the Government powers to extend tobacco-style regulation to a wider range of products, including vaping products, heated tobacco, nicotine pouches and cigarette papers. Imperial Brands emphasized that most measures will be introduced in phases rather than taking effect immediately.
May.11 by 2FIRSTS.ai
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
UK Disposable Vape Ban Marks One Year as Adult Use Falls to 8% and Youth Use to 13%
UK Disposable Vape Ban Marks One Year as Adult Use Falls to 8% and Youth Use to 13%
One year after the UK ban on single-use disposable vapes took effect, YouGov data commissioned by Action on Smoking and Health shows that 13% of 11-17-year-old vapers and 8% of adult vapers now mainly use disposable products.
Jun.18